ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019
Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program.BMC health services research · 2024Article
- Factors associated with prior completion of colorectal cancer and hepatitis C virus screenings among community health center patients: a cross-sectional study to inform a multi-behavioral educational intervention.Journal of behavioral medicine · 2024Article
- Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants.NPJ genomic medicine · 2023Article
- The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population.Open forum infectious diseases · 2022Article
- Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.Southern medical journal · 2022Article
- Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre.BMJ open quality · 2021Article
- A Big Step Forward in Hepatitis C Screening.Clinical liver disease · 2020Review
- Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection.Journal of clinical and translational hepatology · 2020Review
- Reply to MacDonald et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Population-based screening of hepatitis C virus in the United States.Current opinion in gastroenterology · 2019Review
- Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
In the US household population, hepatitis C virus testing coverage marginally increased between 2013 and 2017 among persons born between 1966 and 1994 (13.2% to 16.8%) and persons born between 1945 and 1965 (12.3% to 17.3%). Testing coverage remains limited and sociodemographic disparities were observed in both populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.